Medistim ASA (OSL:MEDI)

Market Cap	4.48B
Revenue (ttm)	628.08M
Net Income (ttm)	131.14M
Shares Out	18.27M
EPS (ttm)	7.17
PE Ratio	34.18
Forward PE	30.46
Dividend	6.00 (2.45%)
Ex-Dividend Date	May 9, 2025

Volume	2,972
Average Volume	13,271
Open	251.00
Previous Close	245.00
Day's Range	243.00 - 251.00
52-Week Range	130.00 - 276.00
Beta	1.06
RSI	48.70
Earnings Date	Aug 20, 2025

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 154
• Stock Exchange: Oslo Børs
• Ticker Symbol: MEDI

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.